Phase 3 Trial of Nivolumab Shows Survival Advantage in Lung Cancer January 13, 2015December 14, 2022 Matthew Tontonoz
Five Myths about Clinical Trials that Just Won’t Go Away February 22, 2015December 14, 2022 Emily Helck
Merck’s PD-1 Drug Outperforms Ipilimumab for Treatment of Advanced Melanoma March 24, 2015December 14, 2022 Matthew Tontonoz
New Clinical Trials to Offer Immunotherapy as Frontline Treatment for Lung Cancer July 7, 2015December 14, 2022 Matthew Tontonoz
Phase 3 Trial Shows Nivolumab Improves Survival in Advanced Kidney Cancer July 20, 2015December 14, 2022 Matthew Tontonoz